NEW RHEIN
New Rhein is a venture capital firm focused on healthcare therapeutics and medical devices. Its partners and associates are former industry executives with operational and transactional experience. New Rhein invests in businesses that utilize proven products in new applications (e.g., new indications, new dosage forms, 505(b2)). The company compiles syndicates of operationally focused investors who together bring a wealth of experience and a broad network of relationships to support its portfoli... o companies in the development, regulatory, reimbursement, marketing, and/or contract manufacturing. New Rhein provides an understanding of what would be attractive to strategic partners and works backward to help its portfolio companies build their value proposition. Prior New Rhein investments have included ophthalmic pharmaceuticals, molecular diagnostics, and respiratory drug/device inhalers.
NEW RHEIN
Founded:
2011-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Sitelinks Search Box GStatic Google Static Content Google Cloud COVID-19 Sectigo SSL
Similar Organizations
Almi Invest GreenTech
Almi Invest GreenTech is a venture capital company and an active start-up investor.
Drumbeat Ventures
Drumbeat Ventures is a venture capital firm makes investments in breakout consumer brands.
Headline
Headline is a global venture capital firm investing in winning teams across stages and geographies.
New Enterprise Associates
New Enterprise Associates is a global venture capital firm investing in technology and healthcare.
Technikos
Technikos is a London based venture capital fund specialising in medical technology.
TGE Capital
Global VC Firm Investing In The Web 3
Venrock
Venrock is a venture capital firm investing in technology and healthcare companies.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-29 | Theranica | New Rhein investment in Series C - Theranica | 45 M USD |
| 2020-10-06 | Butterfly Medical | New Rhein investment in Series B - Butterfly Medical | 7 M USD |
| 2020-09-24 | American Injectables | New Rhein investment in Series A - American Injectables | 10 M USD |
| 2018-12-19 | Neuraptive Therapeutics | New Rhein investment in Series A - Neuraptive Therapeutics | 11.5 M USD |
| 2017-09-06 | Neuraptive Therapeutics | New Rhein investment in Seed Round - Neuraptive Therapeutics | 1000 K USD |
| 2016-11-30 | Softhale | New Rhein investment in Series A - Softhale | N/A |
| 2014-05-12 | Chase Pharmaceuticals | New Rhein investment in Series B - Chase Pharmaceuticals | 21 M USD |
| 2012-12-12 | Biocartis | New Rhein investment in Series D - Biocartis | 34.5 M EUR |
More informations about "New Rhein" on Search Engine
New Rhein Healthcare Investors | Venture Capital
New Rhein applies a private equity business model to life sciences venture capital investing, focusing on assets with proven clinical safety and efficacy applied in new ways (i.e. new delivery forms, new indications). Our goal is to develop products that deliver compelling health benefits to patients and compelling economic value to payors.See details»
Team | New Rhein
The New Rhein team draws on its extensive global relationships to source opportunities and develop New Rhein portfolio companies, including through its highly respected and connected Advisory Board and the network of industry executives who actively participate in New Rhein’s “Executives-in-Residence” program.See details»
New Rhein Healthcare Investors | Portfolio
Portfolio. New Rhein Funds II and III have invested in seven companies developing proprietary drug/device platforms for the treatment of COPD, BPH, COVID-19, migraine etc. Past Deals. New Rhein Fund 18 is currently invested in five companies across North America, Europe, and Israel.See details»
Press | New Rhein Healthcare Investors
Oct 18, 2022 Neuraptive Therapeutics Announces Key Organizational Updates to Support the Company’s Advancements. Oct 18, 2022. Theranica Achieves Positive Results in Placebo-Controlled Pivotal Trial of Nerivio®. Sep 19, 2022. New Study Suggests REN Comparable to Standard Care Prescribed Medications. Sep 12, 2022.See details»
Investment Criteria | New Rhein Healthcare Investors
Investment Criteria. New Rhein is a global venture capital fund with a private equity approach to investing. We take significant ownership positions in pharma and medical device companies with clinical-stage assets.See details»
New Rhein - Crunchbase Investor Profile & Investments
New Rhein is a venture capital firm focused on healthcare therapeutics and medical devices. Its partners and associates are former industry executives with operational and transactional experience. New Rhein invests in businesses that utilize proven products in new applications (e.g., new indications, new dosage forms, 505 (b2)).See details»
Theranica Secures $45 Million Series C Funding Round - New Rhein …
Aug 29, 2022 Theranica Secures $45 Million Series C Funding Round. Proceeds to Fund U.S. Commercial Expansion of Migraine Treatment Device, Nerivio®. Financing Led by Philadelphia-Based New Rhein Healthcare, Selected Additional Co-Investors to Join Round at Final Closing. NETANYA, Israel and MONTCLAIR, N.J., Aug. 29, 2022 /PRNewswire/ …See details»
New Rhein Healthcare Investors | LinkedIn
New Rhein is a Venture Capital/ Private Equity investor. Its partners are former pharmaceutical industry executives having both operational and M&A experience. New Rhein invests in...See details»
New Rhein Healthcare announces first closing of its inaugural fund
Dec 19, 2018, 16:36 ET. Share this article. PHILADELPHIA, Dec. 19, 2018 /PRNewswire/ -- New Rhein Healthcare Investors, an international private equity firm focused on healthcare therapeutics...See details»
New Rhein - Investments, Portfolio & Company Exits - Crunchbase
Highlights. Investments 9. Lead Investments 6. Diversity Investments 1. Exits. Unlock for free. About. New Rhein has made 9 investments. Their most recent investment was on Sep 20, 2023, when Corsair Pharma raised. $23M. New Rhein has invested in Chase Pharmaceuticals on Sep 20, 2023.See details»
New Rhein Healthcare Investor Profile: Portfolio & Exits - PitchBook
Jan 6, 2012 General Information. Company Description. Founded in 2010, New Rhein Healthcare is a venture capital firm based in Philadelphia, Pennsylvania. The firm seeks to invest primarily in healthcare companies across Europe and the United States. Business Details. Website. www.newrhein.com. Year Founded. 2010. Investor Status.See details»
New Rhein opens US headquarters in Philadelphia and expands investment team
PHILADELPHIA, Dec. 12, 2018 /PRNewswire/ -- New Rhein Healthcare Investors, an international private equity firm has announced moving its global headquarters from Chicago to Philadelphia,...See details»
New Rhein - Funding, Financials, Valuation & Investors
Funding. New Rhein has raised 3 funds, their latest being New Rhein ll. Funds Raised. Number of Funds 3. New Rhein has raised 3 funds, their latest being New Rhein ll. Unlock even more features with Crunchbase Pro. Start Your Free Trial. New Rhein is a global venture capital firm investing in healthcare.See details»
The New Rhein Foundation Commits Funding for Young …
Mar 9, 2023 The New Rhein Foundation (NRF), a private foundation created in 2022, has chosen Conquer Cancer, the ASCO Foundation’s Young Investigator Award (YIA) program as one of the first initiatives to benefit from its grant funding.See details»
Advisory Board | New Rhein Healthcare Investors
New Rhein’s advisory board is a select group of industry leaders who help New Rhein source deals, run due diligence on prospective portfolio companies, and manage the companies we ultimately choose to invest in.See details»
Neuraptive Therapeutics Appoints Robert S. Radie as Chief …
Jun 23, 2020 New Rhein is a venture capital/early growth stage fund manager whose investment strategy focuses on proven molecules used in new ways, such as new delivery forms and potential new uses and...See details»
New Rhein Healthcare 2021: Fund Profile, Investments & Returns …
Description. New Rhein Healthcare 2021 is a 2022 vintage private equity growth expansion fund managed by New Rhein Healthcare. The fund is located in Philadelphia, Pennsylvania and invests in the United States and Europe. The fund targets to invest in the healthcare devices, supplies, pharmaceutical and biotechnology sectors. Contact Information.See details»
American Injectables Inc. Secures $10 Million in Series A …
Sep 24, 2020 New Rhein is a venture capital/early growth stage fund manager whose investment strategy focuses on proven molecules used in new ways, such as new delivery forms and potential new uses and...See details»
New Rhein - Contacts, Employees, Board Members, Advisors
Investment Firm. New Rhein. Connect to CRM. Summary Financials Investments People Technology Signals & News Similar Companies. Highlights. Employee Profiles 4. Contacts 9. About. New Rhein has 4 current employee profiles, including VP Nishant Rastogi. Contacts. Job Department. Executive Management. 1 email found. View.See details»
American Injectables Inc. Secures $10M in Series A Financing
Sep 24, 2020 New Rhein is a venture capital/early growth stage fund manager whose investment strategy focuses on proven molecules used in new ways, such as new delivery forms and potential new uses and indications. In this way, New Rhein limits science-based risk and concentrates on development and execution.See details»